Technical Analysis for NURO - NeuroMetrix, Inc.

Grade Last Price % Change Price Change
grade F 0.64 -1.42% -0.01
NURO closed down 1.42 percent on Friday, May 24, 2019, on 25 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical NURO trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
20 DMA Resistance Bearish -1.42%
1,2,3 Retracement Bearish Bearish Swing Setup -1.42%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.42%
Wide Bands Range Expansion -1.42%
Oversold Stochastic Weakness -1.42%
1,2,3 Retracement Bearish Bearish Swing Setup -5.88%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -5.88%
Bullish Engulfing Bullish -5.88%

Older signals for NURO ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
NeuroMetrix, Inc., a medical device company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders, such as those associated with carpal tunnel syndrome, lumbosacral disc disease, spinal stenosis, and diabetes. The company focuses on the diagnosis and treatment of neurological complications of diabetes, including diabetic peripheral neuropathy (DPN) and median neuropathy. Its marketed products include NC-stat DPNCheck, a device used to evaluate systemic neuropathies, such as DPN at the point-of-care; SENSUS pain therapy device, a transcutaneous electrical nerve stimulator used for chronic and intractable pain relief; and ADVANCE NCS/EMG system, a platform for the performance of traditional nerve conduction studies and invasive electromyography procedures for the assesment of CTS, low back and leg pain, and DPN, as well as consumables and accessories. The company is also developing SENTINEL device that provides sensory enhancement in the feet targeted at patients who have lost sensory perception in the lower extremities. NeuroMetrix, Inc. distributes its products directly through its direct sales force and independent sales representatives to physicians, clinics, hospitals, managed care organizations, retail health businesses, and independent distributors consisting of primary care, internal medicine, orthopedic and hand surgeons, pain medicine physicians, neurologists, physical medicine and rehabilitation, physicians, and neurosurgeons, as well as endocrinology and podiatry markets primarily in the United States, the United Kingdom, the Netherlands, and India. The company was founded in 1996 and is headquartered in Waltham, Massachusetts.
Medicine Pain Diabetes Neuroscience Pain Management Nervous System Neuromodulation Neurophysiology Neurotechnology Diabetic Peripheral Neuropathy Electrodiagnosis Acute Pain Carpal Tunnel Syndrome Peripheral Neuropathy Transcutaneous Electrical Nerve Stimulation
Is NURO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.77
52 Week Low 0.6
Average Volume 155,637
200-Day Moving Average 1.0461
50-Day Moving Average 0.8964
20-Day Moving Average 0.7078
10-Day Moving Average 0.6586
Average True Range 0.0589
ADX 33.18
+DI 12.5578
-DI 18.7272
Chandelier Exit (Long, 3 ATRs ) 0.7033
Chandelier Exit (Short, 3 ATRs ) 0.7967
Upper Bollinger Band 0.8395
Lower Bollinger Band 0.5761
Percent B (%b) 0.24
BandWidth 37.213902
MACD Line -0.073
MACD Signal Line -0.0788
MACD Histogram 0.0058
Fundamentals Value
Market Cap 1.19 Million
Num Shares 1.86 Million
EPS -19.02
Price-to-Earnings (P/E) Ratio -0.03
Price-to-Sales 0.21
Price-to-Book 0.63
PEG Ratio -0.01
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.70
Resistance 3 (R3) 0.70 0.69 0.69
Resistance 2 (R2) 0.69 0.67 0.69 0.69
Resistance 1 (R1) 0.66 0.66 0.66 0.66 0.68
Pivot Point 0.65 0.65 0.64 0.65 0.65
Support 1 (S1) 0.62 0.63 0.62 0.62 0.60
Support 2 (S2) 0.61 0.62 0.61 0.59
Support 3 (S3) 0.58 0.61 0.59
Support 4 (S4) 0.58